Efficacy and Safety of Setmelanotide, a Melanocortin-4 Receptor Agonist, for Obese Patients: A Syste...
Efficacy and Safety of Setmelanotide, a Melanocortin-4 Receptor Agonist, for Obese Patients: A Systematic Review and Meta-Analysis
About this item
Full title
Author / Creator
Ferraz Barbosa, Bárbara , Aquino de Moraes, Francisco Cezar , Bordignon Barbosa, Camila , Palavicini Santos, Plínio Takashi Karubi , Pereira da Silva, Izael , Araujo Alves da Silva, Bruno , Cristine Marques Barros, Jamile , Rodríguez Burbano, Rommel Mario , Pereira Carneiro dos Santos, Ney and Rodrigues Fernandes, Marianne
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
Background: A malfunction in the melanocortin-4 receptor (MC4R) is associated with obesity in rare genetic syndromes; setmelanotide is a new drug that activates this receptor and is being used to treat severe obesity. This meta-analysis evaluated the efficacy and safety of setmelanotide for weight loss in severe obesity linked to human MC4R deficie...
Alternative Titles
Full title
Efficacy and Safety of Setmelanotide, a Melanocortin-4 Receptor Agonist, for Obese Patients: A Systematic Review and Meta-Analysis
Authors, Artists and Contributors
Author / Creator
Aquino de Moraes, Francisco Cezar
Bordignon Barbosa, Camila
Palavicini Santos, Plínio Takashi Karubi
Pereira da Silva, Izael
Araujo Alves da Silva, Bruno
Cristine Marques Barros, Jamile
Rodríguez Burbano, Rommel Mario
Pereira Carneiro dos Santos, Ney
Rodrigues Fernandes, Marianne
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10608339
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10608339
Other Identifiers
ISSN
2075-4426
E-ISSN
2075-4426
DOI
10.3390/jpm13101460
